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ABSTRACT 
 
Background:  Pancreatic fistula (PF) is a major source of morbidity following distal 
pancreatectomy (DP).  Our aim was to identify risk factors related to PF following DP and to 
determine the impact of technique of transection and stump closure. 
Methods:  We performed a retrospective review of 215 consecutive patients who underwent DP.  
Perioperative and postoperative data were collected and analyzed with attention to PF as defined 
by the International Study Group of Pancreatic Fistula (ISGPF). 
Results:  PF developed in 36 patients (16.7%); fistulas were classified as Grade A (44.4%), B 
(44.4%), or C (11.1%).  The pancreas was transected with stapler (n=139), cautery (n= 70) and 
scalpel (n= 3).  PF developed in 19.8% of remnants which were stapled/oversewn and 27.7% that 
were stapled alone (p=0.4).  Of the 69 pancreatic remnants transected with cautery and 
oversewn, a fistula developed in 4.3% (p=0.004 compared to stapled/oversewn; p=0.006 
compared to stapled/not sewn).  The median length of post-operative hospital stay was 
significantly increased in patients who developed PF (10 vs. 6 days, p=0.002)   
Conclusion:  The method of transection and management of the pancreatic remnant plays a 
critical role in the formation of PF following DP.  This series suggests that transection using 
electrocautery followed by oversewing of the pancreatic remnant has the lowest risk of PF.   
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INTRODUCTION 
 
 Distal pancreatectomy (DP) is the procedure of choice for benign or malignant lesions in 
the pancreatic body or tail.  The typical procedure consists of resection of the pancreatic 
parenchyma at a variable point to the left of the superior mesenteric vein-portal vein axis, and 
may include concomitant removal of the spleen.  For decades, DP had been associated with high 
morbidity and low but measurable mortality.  In recent years, the mortality rate after DP has been 
reduced to less than five percent in high volume centers1-5, however morbidity rates remain high 
ranging from 10-47%3,6-8.  Pancreatic fistula is the most frequently reported complication and the 
primary cause of post-operative morbidity following DP6-10.  Development of pancreatic fistula 
often leads to further complications such as intra-abdominal abscess, sepsis, hemorrhage, 
delayed gastric emptying, and occasionally malabsorption.  These additional complications have 
important implications for the healthcare system, often with additional procedures, increased 
length of hospital stay and increased cost9-11.   
 While it is clear that pancreatic fistula remains a problem following DP, the risk factors 
for development of fistula are not well defined.  Obesity, patient age, trauma, malignancy, duct 
obstruction and texture of the pancreatic parenchyma have all been implicated as potential risk 
factors9,12.  However, surgical technique is also considered an important risk factor for the 
development of pancreatic fistula9.  A wide variety of surgical techniques for parenchymal 
transection and closure of the pancreatic remnant have been described in an effort to reduce the 
occurrence of fistula.  These techniques include stapled closures, sutured closures, combined 
stapled and sutured closures, ultrasonic dissection, sealing with fibrin glue, application of mesh, 
seromuscular flaps, pancreaticoenteric anastomosis and ligation of the main pancreatic duct at 
the transection line3,6-9,11-21.  Currently, there is no consensus as to the optimal surgical technique 
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for pancreatic transection and stump closure during distal pancreatectomy.  The purpose of this 
study is to determine the impact of the type of pancreatic transection and closure of the 
pancreatic remnant on the formation of pancreatic fistula. 
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MATERIAL AND METHODS 
 
 Our Institutional Review Board approved this retrospective review of all patients who 
underwent distal pancreatectomy at Thomas Jefferson University Hospital from January 1996 
through July 2008.  Patients who underwent distal pancreatectomy were identified using 
electronic search of a surgical database. The indications for distal pancreatectomy included 
primary pancreatic processes, non-pancreatic malignancies and trauma.  No patients were 
excluded from the study. Octreotide was rarely used in the preoperative, prophylactic 
setting, but was often used in patients with documented pancreatic fistulae. 
Patient data including demographics, comorbidities, additional procedures, method of 
pancreatic transection, management of the pancreatic remnant, operative time, blood loss, 
pathology, and post-operative complications were collected using hospital electronic record and 
chart review.  These data were compiled and further analyzed.  The primary endpoint was 
pancreatic fistula.  Pancreatic fistula was defined using the International Study Group on 
Pancreatic Fistula (ISGPF) definition:  drainage of any measurable volume after post-operative 
day 3, with an amylase content of greater than three times the normal serum value22.  Pancreatic 
fistulas were retrospectively graded according to the ISGPF grading system22.  Secondary 
endpoints were all complications. 
Statistical Analysis 
Continuous variables (such as length of post-operative hospital stay) were compared 
using a two-sided Student’s t-test.  Qualitative variables (such as pancreatic fistula rates) were 
compared using Fisher’s exact test.  Bivariate crosstabulations, with Chi-square statistics, to 
assess bivariate associations between selected risk factors and the occurrence of fistulas were 
performed.  A multivariate logistic regression analysis which modeled the occurrence of fistulas 
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as a function of all risk factors with significant bivariate associations and also selected other 
variables (i.e., age group, sex, body mass index, and estimated blood loss) to assess and control 
for confounding was performed.  A p-value less than 0.05 was considered significant.  SAS 
Release 9.2 statistical software (SAS Institute, Inc., Cary, NC) was used for all analyses. 
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RESULTS 
 
 From January 1996 to July 2008, 215 patients underwent distal pancreatectomy.  There 
were more females (n=125; 58%) than males (n=90; 42%).  The mean age of patients was 58.8 
years (range, 18-87 years).  Indications for distal pancreatectomy are listed in Table 1.  More 
patients were operated on for benign lesions (61%) than for malignancies (39%).  The most 
frequent benign lesions were cystadenomas (12.6%), intra-ductal papillary mucinous neoplasms 
(IPMN; 9.8%), and neuroendocrine tumors (9.8%).  Eight patients (3.7%) underwent distal 
pancreatectomy for pancreatic trauma.  Of the malignant lesions, pancreatic ductal 
adenocarcinoma (19%) and neuroendocrine tumors (9.8%) were the most frequent indications.   
 Open distal pancreatectomy with splenectomy was performed in 84% of patients (Table 
2).  Open distal pancreatectomy with splenic preservation was performed in 9%.  Laparoscopic 
resection was attempted in 16 patients (7.4%) and completed in 13 patients (6%).  Additional 
organs, excluding the spleen, were resected in 108 patients (50%); the majority of these were 
incidental cholecystectomies (Table 3).  The mean operative time was 274 minutes (range 83-
665) and the average blood loss was 621 milliliters (range 0-5400).  The pancreas was transected 
using a stapler in 139 patients, electrocautery in 70 patients, and scalpel in 3 patients (unknown 
in 3 patients) (Figure 1).  Of the 139 patients who were transected with stapler, the pancreatic 
remnant was oversewn in 91 patients, not oversewn in 47 patients, and sealed with tissue glue in 
one patient.  Of the 70 patients who were transected with electrocautery, the pancreatic remnant 
was oversewn in 69 patients and not oversewn in one patient.  For the 3 patients who were 
transected with scalpel, the remnant was oversewn in one patient, not oversewn in one patient, 
and pancreatico-jejunostomy was performed in one patient.  
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Pancreatic fistula was the most common complication, occurring in 36 patients (16.7%).  
Pancreatic fistula occurred in 50% of patients undergoing laparoscopic spleen preserving 
distal pancreatectomy, 44.4% of patients undergoing laparoscopic distal pancreatectomy 
and splenectomy, 15.6% of patients undergoing open distal pancreatectomy and 
splenectomy, and 10.0% of patients undergoing open spleen preserving distal 
pancreatectomy.  The characteristics of patients who developed a pancreatic fistula are 
described in Table 4.  Fistulas were classified as Grade A in 16 patients (44.4%), Grade B in 16 
patients (44.4%), and Grade C in 4 patients (11.1%).  Pancreatic fistula developed in 27.7% of 
patients that were stapled and not oversewn, 19.8% of patients where the remnants were stapled 
and oversewn, and only in 4.3% of remnants that were divided by cautery and oversewn (Figure 
1).  The fistula rate for remnants that were cauterized and oversewn was significantly lower as 
compared to the leak rate in both stapled and oversewn (p=0.004) and stapled and not oversewn 
(p=0.0006).  There was no difference in the incidence of pancreatic fistula between patients 
who had additional organs (excluding spleen) resected compared to those where no 
additional organs were resected (13% vs. 20.6%; p=0.15).  Of the 13 laparoscopic cases (all 
stapled and none oversewn), six (46.2%) developed pancreatic fistula.   
The median length of post-operative hospital stay was significantly increased in patients 
who developed pancreatic fistula, as compared to those who did not develop a fistula (10 days 
versus 6 days; p=0.002) (Table 4).  Pancreatic fistula was treated with maintenance of JP 
drainage alone in 41.7% of patients and maintenance of JP drainage plus octreotide in 30.6% of 
patients.  Percutaneous drain placement by interventional radiology was required in 22.2% of 
fistulas.  Three patients who developed fistula required re-operation; all three had Grade C 
fistulas. 
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 Fifty-five patients (25.6%) developed at least one post-operative complication (Table 5).  
There were two peri-operative deaths (0.9%).  One was a patient with malignant 
pheochromocytoma adherent to the pancreas and spleen, who developed post-operative sepsis 
and multi-system organ failure (death on post-operative day #48).  The other mortality was a 
patient with metastatic melanoma who expired from unexpected cardiac arrest in the post-
operative period (death on post-operative day # 21).   
 We also examined fistula rates based on surgical volume at the entire institution.  As 
one can see from Figure 2, the volume of pancreatic surgery increased by several-fold 
beginning in 2006. Prior to this point, there were a total of 93 distal pancreatectomies, 
while starting in 2006, there were a total of 120 distal pancreatic resections.  When 
calculating leak rates pre- and post-2006, there is a significant decrease in leak rates (26% 
vs. 10%, p=0.003). 
Bivariate analyses showed that pancreatic transection using a stapler, not oversewing the 
pancreatic remnant, and low surgeon volume (fewer than 20 total cases performed) were all 
significantly associated with the development of pancreatic fistula (Table 6).  While the bivariate 
analyses show significant differences in the likelihood of a pancreatic fistula, as noted, none of 
these differences remained significant in the multivariate logistic regression analysis (Table 7), 
although the method of pancreatic transaction was borderline significant (p=0.058) with a hazard 
ratio of 3.2. 
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DISCUSSION 
 
 In the present study, we analyzed the morbidity and mortality associated with DP, with 
particular attention to pancreatic fistula and surgical technique.  For the 215 patients in this 
series, we report a mortality rate of 0.9% and a morbidity rate of 25.6%.  Pancreatic fistula was 
the most frequent complication, occurring in 16.7% of patients.  We found a significantly lower 
fistula rate in pancreatic remnants that were transected by cautery and oversewn (4.3%), as 
compared to remnants that were stapled and oversewn (19.8%; p=0.004) or stapled and not 
oversewn (27.7%; p=0.0006).  In our relatively small laparoscopic group, 46.2% developed 
pancreatic fistula.  Median length of stay was significantly increased in patients who developed 
pancreatic fistula compared to those who did not (10 days versus 6 days; p=0.002).   
Our data support the claim that DP can be performed with low mortality1-5, however, 
morbidity remains high largely due to pancreatic fistula.  Our pancreatic fistula rate falls within 
the range of 3-26% reported in the literature3,6-8.  This wide variability of fistula rates is likely 
due to discrepancy in the diagnostic criteria used to define pancreatic fistula across the various 
studies.  A review by Bassi et al identified more than 25 definitions of pancreatic fistula that vary 
based on the daily amount of drain output, amylase level of the fluid and duration of drainage23.  
In this study, pancreatic leaks were defined and classified according to the standard definitions 
outlined by the ISGPF.22  Pancreatic fistula was defined as a drain output of any measurable 
volume of fluid on or after post-operative day three with an amylase content greater than three 
times the serum amylase content.  Grade A fistulas, or “transient fistulas”, have little clinical 
impact.  Grade B fistulas require a change in management, usually have persistent drainage after 
three weeks and may be associated with signs of infections.  Grade C fistulas are associated with 
a major change in clinical pathway and patient stability may be borderline.  The ISGPF 
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definition has resulted in an internationally accepted standard definition of pancreatic fistula that 
allows for better comparisons between fistula rates from different institutions.  Using the ISGPF 
definition, our pancreatic fistula rate of 16.7% falls in the middle of the range of reported rates in 
the literature. Given the fact that the ISGPF definition was not published until 2005, many leaks 
were identified and graded in a retrospective fashion by reviewing inpatient medical records.   
Management of pancreatic fistula following DP has not been standardized.  The majority 
of the pancreatic fistulas that occurred in our series were either Grade A or Grade B.  All of these 
were managed conservatively.  Intra-operatively placed drains were maintained and additional 
percutaneous drains were placed when necessary for undrained collections.  Octreotide was 
administered to patients at the discretion of the surgeon.  Patients were additionally supported 
with parenteral nutrition when indicated.  Most patients had a delay in hospital discharge as a 
result of their fistula.  With conservative management, all Grade A and B fistulas closed 
spontaneously.  Four Grade C fistulas occurred in our study.  Three of these required reoperation 
for either hemorrhage or abdominal sepsis.  Mortality occurred in two patients with Grade C 
fistulas; both of these patients had malignant tumors with metastatic disease.  The increased 
utilization of healthcare resources and potential severity of disease associated with pancreatic 
fistula illustrates the need for effective methods to reduce their incidence. 
The optimal surgical technique for both pancreatic transection and closure of the 
pancreatic remnant remains a debate.  A multitude of surgical techniques and instruments have 
been proposed for reducing the occurrence of pancreatic fistula.  A partial list of techniques 
includes hand-sutured closure, stapled closure, sutured plus stapled closure, sealing with fibrin 
glue, application of mesh, seromuscular flaps, ultrasonic dissection, bipolar scissors, 
pancreaticoenteric anastomosis and ligation of the main pancreatic duct3,6-9,11-21.  The most 
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frequently used techniques are the suture and stapler closures of the pancreatic remnant.  Kleeff 
et al have observed a significantly increased risk of pancreatic fistula with stapled closure9.  In 
contrast, other investigators have reported increased pancreatic fistula rates with sutured closure 
of the pancreatic remnant3,14,15,24.  Many have concluded that the method of stump closure has no 
impact on the incidence of pancreatic fistula12,13,21,25,26.   
In our study, the surgical technique most commonly involved transection of the 
pancreatic parenchyma with a stapler or electrocautery. The pancreatic remnant was then either 
oversewn or not oversewn at the discretion of the attending surgeon.  We found a significantly 
lower fistula rate in pancreatic remnants that were cauterized and oversewn (4.3%), as compared 
to remnants that were stapled and oversewn (19.8%; p=0.004) or stapled and not oversewn 
(27.7%; p=0.0006).  Bivariate analysis confirmed the importance of method of transaction 
(p=0.012), type of remnant closure/sealing (p=0.012), and surgeon volume (p<0.001) for 
pancreatic fistula after distal pancreatectomy.  Multivariate analysis failed to demonstrate one 
single independent factor, although the method of pancreatic transection showed a nearly 
significant increase in risk of fistula (p=0.058, hazard ratio=3.2) with the use of non-stapled 
transection.  It is likely that if there were more patients in our study, that this factor would have 
reached statistical significance. 
Interestingly, surgeon volume was a significant factor in the determination of pancreatic 
fistula.  We used a cutoff of <20 procedures during the period of this study.  This left us with 
groups that were relatively equal in size.  There were a total of 24 surgeons who performed distal 
pancratectomies in this series, with a volume range of one to 67.  The median number of cases 
performed was 2.5, and there were three surgeons who performed more than 20 procedures with 
a leak rate of 10% in the high volume group, as compared to 28% for the lower volume surgeons.  
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This factor was not, however, significant on multivariate analysis.  Surgeon volume has not been 
thoroughly examined as a specific risk factor for pancreatic fistula after pancreatic resection, and 
in fact, ours is the first one that we could find that addressed its potential importance for leaks 
after distal pancreatectomy. Another fact that we found to be significant was institutional 
volume. Starting at the beginning of 2006, there was a dramatic increase in the number of 
pancreatic resections performed.  In 2006, 2007, and half of 2008, there were a total of 120 
distal pancreatectomies a year (mean=40 per year), while in the prior years of the study, 
there were 93 distal resections (mean=9.5). As one would expect, the increased institutional 
volume lead to a significant decrease in the number of pancreatic fistulae (26% vs. 10%, 
p=0.003). 
Several authors state that the texture of the pancreatic parenchyma is an important risk 
factor associated with the development of post-operative pancreatic fistula.3,12,13  Fibrotic 
pancreatic tissue is believed to be less likely to leak as compared to soft pancreatic parenchymal 
tissue, as long as the continuity of the main pancreatic duct is not compromised.  Due to the 
retrospective nature of our study, we were unable to include pancreatic texture as a variable in 
our analysis as we found that it was not consistently reported in the operative reports and medical 
records that were reviewed.   
The administration of prophylactic octreotide to reduce the incidence of post-
operative pancreatic fistula remains controversial.  Several studies have shown that 
prophylactic octreotide reduces the rate of pancreatic fistula following elective pancreatic 
resection.27-30  In contrast, other authors have shown no benefit to the use of prophylactic 
octreotide.31,32  Prophylactic octreotide was not included as a variable in our study.  The 
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retrospective nature of our study precluded its use as a variable for analysis, as we found 
that it was not consistently reported in the reviewed medical records.   
Laparoscopic surgery has quickly been adopted as the standard for a variety of solid 
organ resections.  In the surgical treatment of pancreatic disease, laparoscopic resections are 
becoming increasingly popular.  To date, most reports of laparoscopic distal pancreatectomy are 
small series from single institutions.33-38  The occurrence of pancreatic fistula following 
laparoscopic distal pancreatectomy in these studies has been reported as ranging from 13-50%.33-
38
  A large, multi-center retrospective reviewe comparing laparoscopic distal 
pancreatectomy with open distal pancreatectomy reported shorter length of hospital stay 
with laparoscopic distal pancreatectomy and no significant differences in major 
complication rate or pancreatic fistula rate when compared to open distal 
pancreatectomy.39  In our series, laparoscopic distal pancreatectomy was attempted in 16 
patients and completed in 13 patients.  Pancreatic fistula occurred in 6 (42.6%) of these 13 
patients.  This fistula rate is at the higher end of the reported ranges in the literature.  We expect 
that as this technique becomes more widely used and newer techniques are developed, the 
incidence of pancreatic fistula will decrease. 
Our institution has recently opened a randomized, prospective clinical trial evaluating the 
method of pancreatic stump closure following distal pancreatectomy (NCT00889213).  In this 
trial, patients are stratified by pancreatic texture and randomized to one of two methods of 
closure—standard closure (investigator’s choice of stapler, cautery or sharp transaction with 
suture closure at surgeon’s discretion) or experimental closure which adds an autologous 
falciform patch and the placement of fibrin glue (Vitagel) between the parenchyma and the 
patch.  This trial began accruing patients in August 2008 and has an accrual goal of 190 patients.  
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We hope that this trial will help to resolve the controversy around management of the pancreatic 
stump after distal pancreatectomy.   
In summary, pancreatic fistula remains a significant cause of the morbidity associated 
with distal pancreatectomy.  The method of transection of the pancreatic parenchyma and 
management of the pancreatic remnant appear to be related to the formation of pancreatic fistula.  
This series suggests that transection using electrocautery followed by oversewing of the 
pancreatic remnant minimizes the formation of pancreatic fistula.  Additional prospective, 
randomized studies are needed in order to determine the optimal surgical technique for 
parenchymal transection and remnant closure during distal pancreatectomy to minimize the 
occurrence of post-operative pancreatic fistula. 
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Table 1.  Indications for distal pancreatectomy. 
Indications for Distal Pancreatectomy 
(n=215 patients) 
 
# (%) of 
patients 
Benign  
   Cystadenoma (serous and mucinous)       27 (12.6) 
   IPMN       21   (9.8) 
   Neuroendocrine       21   (9.8) 
   Solid Pseudopapillary Neoplasm       13   (6.0) 
   Pseudocyst         8   (3.7) 
   Trauma         8   (3.7) 
   Chronic Pancreatitis         7   (3.3) 
   Cysts         7   (3.3) 
   Microcystic Adenoma         6   (2.8)   
   Abscess         2   (0.9) 
   Pancreatic Intraepithelial Neoplasia         2   (0.9) 
   Inflammatory Myofibroblastic Tumor         1   (0.5) 
   Miscellaneous         9   (4.2) 
Total Benign     132  (61%) 
  
Malignant  
   Ductal Adenocarcinoma       41 (19.0) 
   Neuroendocrine       21   (9.8) 
   Metastatic Tumors         8   (3.7) 
   Mucinous Cystadenocarcinoma         3   (1.4) 
   Gastric Cancer         3   (1.4) 
   Adenosquamous Carcinoma         2   (0.9) 
   Anaplastic Carcinoma         2   (0.9) 
   Acinar Cell Carcinoma         1   (0.5) 
   Lymphoma         1   (0.5) 
   Liposarcoma         1   (0.5) 
Total Malignant       83  (39%) 
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Table 2.  Demographics and clinical characteristics. 
Demographic and Clinical Characteristics 
(Total=215 patients) 
Mean Age in years (range) 58.8 (18-87) 
  
Female 125 (58%) 
Male   90 (42%) 
  
Race  
Caucasian 194 (90.2%) 
African American     13   (6.0%) 
Hispanic       3   (1.4%) 
Other       5   (2.3%) 
  
Mean Body Mass Index (range) 26.9 (16.4-60.1) 
  
Procedure  
Open distal pancreatectomy and 
splenectomy 180 (83.7%) 
Open distal pancreatectomy (spleen 
preserving) 20 (9.3%) 
Laparoscopic distal pancreatectomy               
and splenectomy 9 (4.2%) 
Laparoscopic distal pancreatectomy 
(spleen preserving)    4 (1.9%) 
Open subtotal pancreatectomy 2 (0.9%) 
  
Patients with additional organs resected 108 (50.2%) 
  
Mean operative time in minutes (range) 274 (83-665) 
  
Mean blood loss in milliliters (range) 621 (0-5400) 
  
Median length of post-operative hospital 
stay in days (range) 6 (2-61) 
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Table 3.  Additional operative procedures performed. 
Additional Operative Procedures* 
 
No. (%) of Patients 
Cholecystectomy             66 (30.1) 
Gastrectomy             22 (10.2) 
Partial colectomy             10  (4.7) 
Wedge resection of liver               8  (3.7) 
Nephrectomy               8  (3.7) 
Adrenalectomy               6  (2.8) 
Small bowel resection               3  (1.4) 
Hysterectomy and bilateral salpingo-oophorectomy               2  (0.9) 
Oophorectomy               1  (0.5) 
Resection of omental mass               1  (0.5) 
Orthotopic liver transplant               1  (0.5) 
Pancreaticojejunostomy               1  (0.5) 
Resection of retroperitoneal mass               1  (0.5) 
*Some patients had more than one additional procedure
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 Table 4.  Characteristics of patients with pancreatic fistula. 
Clinical Characteristics of Patients with Pancreatic Fistula 
(n=36) 
Mean age years (range) 53.8 (21-77) 
  
Gender  
Female 20 (55.6%) 
Male 16 (44.4%) 
  
Mean Body Mass Index (range) 26.5 (17.9-43) 
  
Procedure  
Open distal pancreatectomy and 
splenectomy          28 (77.8%) 
Open distal pancreatectomy (spleen 
preserving)           2   (5.6%) 
Laparoscopic distal pancreatectomy 
and splenectomy           4 (11.1%) 
Laparoscopic distal pancreatectomy  
(spleen preserving)              2   (5.6%) 
  
Additional organs resected 14 (39%) 
  
Median length of post-operative 
hospital stay days (range) 10 (4-61) 
  
Grade of Fistula  
Grade A 16 (44.4%) 
Grade B 16 (44.4%) 
Grade C           4 (11.1%) 
  
Management of Fistula  
JP drain alone 15 (41.7%) 
JP drain + octreotide 11 (30.6%) 
Interventional radiology drainage           8 (22.2%) 
Endoscopic cystgastrostomy           1   (2.8%) 
Re-operation           3   (8.3%) 
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Table 5.  Post-operative complications. 
All Post-operative Complications 
(Total patients=215) 
 # of patients (%) 
Pancreatic fistula 36 (16.7) 
Intra-abdominal abscess 22 (10.2) 
Small bowel obstruction          8  (3.7) 
Respiratory          6  (2.8) 
Cardiac          5  (2.3) 
Sepsis          4  (1.9) 
Wound Infection          3  (1.4) 
Delayed gastric emptying          2  (0.9) 
Mortality           2  (0.9) 
  
Patients with complication       55 (25.6) 
Patients without complication     160 (74.4) 
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Table 6.  Bivariate Analysis 
Bivariate Analysis: Proportion of cases with pancreatic fistula by selected risk factors 
Not stapled Stapled Method of pancreatic 
transection 4/73=5.48% 31/139=22.30% 
Chi-square=9.83, df=1, 
p=0.002 
  Oversewn        Not oversewn            Method of sealing 
pancreatic remnant 21/161=13.04% 15/54=27.78% 
Chi-square=6.30, df=1, 
p=0.012 
High Low 
Surgeon volume 
14/136=10.29%                              22/79=27.85%
Chi-square=11.05, df=1, 
p<.001 
 
 28 
Table 7.  Multivariate Logistic Regression Analysis 
Multivariate Logistic Regression Analysis 
Variable Effect Odds Ratio 
95% 
LCL 
95% 
UCL df 
Wald 
X2 p-value 
50-59 vs. 18-49 0.565 0.188 1.696 
60-69 vs. 18-49 0.524 0.175 1.564 Age 
70+  vs. 18-49 0.521 0.174 1.563 
3 2.0570 0.5607 
Gender Male vs. Female 1.137 0.485 2.666 1 0.0870 0.7680 
25-29.99 vs.<25     1.238 0.498 3.081 Body Mass Index 
>=30 vs. <25       0.658 0.237 1.825 2 1.3065 0.5203 
200-499 vs. <200                              2.023 0.684 5.981 
500-799 vs. <200                               1.744 0.440 6.903 Estimated Blood Loss 800+ vs. <200                              1.407 0.395 5.014 
3 1.7330 0.6296 
Method of 
pancreatic 
transection 
     Stapled vs. Non-
stapled 3.242 0.962 10.928 1 3.5980 0.0578 
Method of sealing 
pancreatic remnant 
Not oversewn vs. 
Oversewn 1.570 0.669 3.686 1 1.0744 0.2999 
Surgeon volume Low vs. High 1.881 0.785 4.510 1 2.0066 0.1566 
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Figure 1.   
P-J=pancreaticojejunostomy, *p=0.0006, **p=0.004
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Figure 1 Legend—Flowsheet demonstrating the breakdown of patients by method of transection 
of pancreatic remnant, management of the remnant, and fistula rates. 
 
Figure 2.  
 
 
Graph demonstrating increasing volume of distal pancreatectomies by year at Thomas Jefferson 
University Hospital.  
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